Clinical Trials Sponsored by Stanford Cancer Council

Total 597 results

Stanford University
Stanford Cancer Council

Terminated

Metabolic Imaging Predict Histopathologic Response to Preop ChemoXRT for Locally Advanced Rectal CA

Rectal Cancer

United States
Stanford University
AHS Cancer Control Alberta; National Council on Aging (NCOA)

Completed

Healthier Living Canada

Asthma | Chronic Disease

United States
Cancer Council Victoria

Completed

DNA Methylation and 1-C Metabolism Nutrient Intake

DNA Methylation
Trans Tasman Radiation Oncology Group
Cancer Council Queensland; Victorian Cancer Council

Completed

Chemoradiotherapy in Patients With Localised Lung Cancer

Non Small Cell Lung Carcinoma

Australia
Stanford University
University of Hawaii Cancer Research Center

Completed

Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors

Neoplasms | Breast Cancer | Prostatic Neoplasms | Colorectal Neoplasms | Blood Cancer

United States, United Kingdom
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute; Stanford University

Active, not recruiting

Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas

Lymphoma | Relapsed/Refractory T-cell Lymphomas

United States
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center; Stanford University; Rockefeller University

Active, not recruiting

A Study of NKTR-214 in Combination With Nivolumab in Patients With Metastatic and/or Locally Advanced Sarcoma

SARCOMA

United States
Stanford University
National Cancer Institute (NCI)

Completed

Investigation of Two Swallowing Therapy Models During Radiation Therapy for Head and Neck Cancer

Head Neck Cancer

United States
Stanford University
National Cancer Institute (NCI)

Completed

Modified Dakin's Solution in Reducing Radiation-Induced Dermatitis in Patients With Head and Neck Cancer Undergoing Radiation Therapy

Head and Neck Carcinoma | Radiation-Induced Dermatitis

United States
Stanford University
National Cancer Institute (NCI)

Terminated

Ipilimumab and Local Radiation for Selected Solid Tumors

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditions

United States
Stanford University
National Cancer Institute (NCI)

Completed

Phone or Email Reminder in Increasing Vaginal Dilator Use in Patients With Gynecologic Cancers Undergoing Brachytherapy

Cervical Cancer | Endometrial Cancer | Radiation Toxicity | Vaginal Cancer

United States
Stanford University
National Cancer Institute (NCI)

Completed

Brief Behavioral Intervention for Insomnia During Chemotherapy

Breast Cancer | Insomnia

United States
Stanford University
National Cancer Institute (NCI)

Completed

68Ga-PSMA PET/CT or PET/MRI in Evaluating Patients With Recurrent Prostate Cancer

Recurrent Prostate Carcinoma

United States
Stanford University
National Comprehensive Cancer Network

Completed

Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung | Neoplasm Metastasis | Lung Cancer | Brain Cancer

United States
Stanford University
National Cancer Institute (NCI)

Completed

Dakin's Solution in Preventing Radiation Dermatitis in Patients With Breast Cancer Undergoing Radiation Therapy

Breast Cancer | Skin Reactions Secondary to Radiation Therapy

United States
Stanford University
National Cancer Institute (NCI)

Terminated

NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer

Metastatic Prostate Carcinoma | Metastatic Malignant Neoplasm in the Bone | Hormone-Resistant Prostate Cancer

United States
Stanford University
National Cancer Institute (NCI)

Completed

68Ga-DOTA-Bombesin PET/MRI in Imaging Patients With Prostate Cancer

Prostate Carcinoma

United States
Stanford University
National Comprehensive Cancer Network

Completed

Phase I Bortezomib (VELCADE) in Combo With Pralatrexate in Relapsed/Refractory MM

Multiple Myeloma

United States
Stanford University
National Cancer Institute (NCI)

Withdrawn

Cognitive Enhancement Program in Improving Cognitive Function in Breast Cancer Survivors

Breast Cancer | Cancer Survivor | Cognitive/Functional Effects

United States
Stanford University
National Cancer Institute (NCI)

Withdrawn

Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting

Osteosarcoma | Ewing Sarcoma | Childhood Acute Lymphoblastic Leukemia | Vomiting in Infants and/or Children | Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies

United States
Stanford University
National Cancer Institute (NCI)

Completed

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease

Lymphoma

United States
Stanford University
National Cancer Institute (NCI)

Completed

Vaccine Therapy for Multiple Myeloma Utilizing Idiotype-Pulsed Allogeneic Dendritic Cells

Multiple Myeloma

United States
Stanford University
The Latino Cancer Institute

Recruiting

Achieving Equity in Genomic Testing for Breast Cancer Through Partner-Led Strategies and Policies

Breast Cancer

United States
Stanford University
National Cancer Institute (NCI)

Not yet recruiting

Development of 3DMPUS as a Decision Support Tool for Patients With Liver Tumors Undergoing Therapy (3DMPUS)

Liver Cancer, Adult

United States
Stanford University
National Cancer Institute (NCI)

Not yet recruiting

Cancer Prevention & Online Technologies

Skin Cancer
Stanford University
National Cancer Institute (NCI)

Recruiting

Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer

Pancreatic Cyst | Pancreas Disease

United States
Stanford University
National Cancer Institute (NCI)

Terminated

Transarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial Chemoembolization

Recurrent Hepatocellular Carcinoma | Child-Pugh Class A | Child-Pugh Class B

United States, Japan
Stanford University
National Cancer Institute (NCI)

Active, not recruiting

High-Dose Brachytherapy in Treating Patients With Prostate Cancer

Prostate Adenocarcinoma | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer

United States
Stanford University
National Cancer Institute (NCI)

Completed

Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy Volunteers

Pancreatic Carcinoma | Healthy Subject

United States
Stanford University
National Cancer Institute (NCI)

Enrolling by invitation

Evaluation of the Be Vape Free Curriculum of the Tobacco Prevention Toolkit

E-cigarette Use

United States
Stanford University
National Cancer Institute (NCI)

Completed

Fructooligosaccharides in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

Hematopoietic and Lymphoid Cell Neoplasm | Recurrent Hematologic Malignancy

United States
Stanford University
National Cancer Institute (NCI)

Completed

Management of Insomnia in Breast Cancer Patients

Fatigue | Insomnia

United States
Stanford University
National Cancer Institute (NCI)

Terminated

Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Recurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute... and other conditions

United States
Stanford University
National Cancer Institute (NCI)

Terminated

Capecitabine in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Skin

Squamous Cell Carcinoma of the Skin | Recurrent Skin Cancer

United States
Stanford University
National Cancer Institute (NCI)

Completed

Levocarnitine in Treating Patients With Vismodegib-Associated Muscle Spasms

Musculoskeletal Complications

United States
Stanford University
National Cancer Institute (NCI)

Terminated

Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast Cancer

Male Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer

United States
Stanford University
National Cancer Institute (NCI)

Terminated

Recombinant Human Hyaluronidase in Treating Lymphedema in Patients With Cancer

Lymphedema | Malignant Neoplasm

United States
Stanford University
National Cancer Institute (NCI)

Terminated

Stereotactic Body Radiation Therapy and T-Cell Infusion in Treating Patients With Metastatic Kidney Cancer

Clear Cell Renal Cell Carcinoma | Stage IV Renal Cell Cancer | Recurrent Renal Cell Cancer

United States
Stanford University
National Cancer Institute (NCI)

Completed

Promoting Healthy Weight With 'Stability Skills First'

Obesity

United States
Stanford University
National Cancer Institute (NCI)

Terminated

Combination Chemotherapy +/- Radiation in High Risk Hodgkin's Disease

Hodgkin Disease

United States
Stanford University
National Cancer Institute (NCI)

Completed

Cognitive Behavioral Therapy in Treating Anxiety in Patients With Stage IV Non-Small Cell Lung Cancer and Their Caregivers

Anxiety Disorder | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer

United States
Stanford University
National Cancer Institute (NCI)

Withdrawn

Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer

Prostate Cancer | Bladder Cancer | Kidney Tumor
Stanford University
National Cancer Institute (NCI)

Completed

Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Squamous Neck Carcinoma of the Head and Neck Cancer (SCCHN)

United States
Stanford University
National Cancer Institute (NCI)

Withdrawn

Probiotic Supplementation in Preventing Treatment-Related Diarrhea in Patients With Cancer Undergoing Chemotherapy

Diarrhea | Unspecified Adult Solid Tumor, Protocol Specific

United States
Stanford University
National Cancer Institute (NCI)

Completed

Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer

Colorectal Cancer

United States
Klein Buendel, Inc.
Cancer Council Victoria

Completed

Use of Shade in U.S. and Australian City Parks (Shade)

Skin Cancer

United States, Australia
Medical Research Council
Cancer Research UK

Unknown

ICON8: Weekly Chemotherapy in Ovarian Cancer (ICON8)

Ovarian Cancer

United Kingdom
Stanford University
National Cancer Institute (NCI)

Completed

Pilot Study of a Decision Aid Intervention for Family-building After Cancer

Cancer

United States
Stanford University
National Cancer Institute (NCI)

Completed

[18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancer

Liver Cirrhosis | Adult Liver Carcinoma

United States
Stanford University
National Cancer Institute (NCI)

Completed

Stanford Tobacco Treatment Services - Virtual Reality Treatment for Smoking Cessation

Smoking Cessation | MindCotine Virtual Reality Mindful Exposure Therapy

United States

Clinical Trials Sponsored by Stanford Cancer Council

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations